Physician profile
Deborah C Pollack
NPI 1053481937
$795.23
in general payments reported to CMS, 2019-2025
20 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $95.72 · 2021: $18.49 · 2022: $20.66 · 2023: $53.22 · 2024: $268 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $105.28 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $100.93 | 2019-2025 | Gardasil 9, Proquad, Gardasil |
| Seqirus USA INC | $63.33 | 2024-2025 | Flucelvax |
| Sanofi Pasteur INC. | $58.37 | 2020-2024 | |
| Kaleo, INC. | $54.67 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $48.08 | 2019-2024 | |
| Vertical Pharmaceuticals, LLC | $45.71 | 2019-2025 | Relexxii |
| Sanofi-Aventis U.S. LLC | $42.82 | 2024-2025 | |
| Cranial Technologies, INC | $40.03 | 2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $39.16 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $32.60 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $27.00 | 2025 | Neffy |
| Adlon Therapeutics L.P. | $20.41 | 2019 | |
| Corium, LLC | $19.62 | 2025 | Azstarys |
| Neos Therapeutics, Lp | $19.28 | 2024 | Adzenys Xr-Odt |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $17.73 | 2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $16.79 | 2025 | Jornay Pm |
| Shire North American Group INC | $15.27 | 2019 | |
| Glaxosmithkline, LLC. | $14.84 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.